| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_c54bfbd3f7dc53cbf0e6d08cc0b970c9 |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R1-445
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12R2001-445 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/C12Q1-18 |
| classificationIPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12R1-445 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12N1-20
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/C12Q1-18 |
| filingDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_20fb912a0302d7c54f6b8d2bcc5cb9f0
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5155894e16650eda791c41599d44d7e6
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_8d21a82fa2d609495fb55277c5c94a84
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_1ed73fa670260a8077bad72ab87e686f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_0f6419e01d969590d2dcf245345d18e5 |
| publicationDate |
2018-10-17-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
KR-101908411-B1 |
| titleOfInvention |
Novel domestic-type methicillin-resistant Staphylococcus aureus strains and screening method for inhibiting biofilm formation |
| abstract |
The present invention biofilm-forming ability is high methicillin-resistant Staphylococcus aureus (MRSA; Methicillin-resistant Staphylococcus aureus ) 12KKPN53 strain (accession number: KCTC 13226BP), a screening method of a biofilm formation inhibitor using the same, Bio comprising the strain And to a kit and a composition for developing a film formation inhibitor. The methicillin-resistant Staphylococcus aureus (MRSA) strain deposited with the accession number KCTC 13226BP according to the present invention has a remarkably superior ability to form biofilms as compared with other methicillin-resistant Staphylococcus aureus strains, so that a new biofilm formation inhibitor And can be used to develop therapeutic agents for various clinical diseases caused by biofilm formation. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046711-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046743-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046776-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046787-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046649-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046680-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046681-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046693-A
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/KR-20230046622-A |
| priorityDate |
2017-06-20-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |